ID

39080

Descrizione

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan); ODM derived from: https://clinicaltrials.gov/show/NCT01968668

collegamento

https://clinicaltrials.gov/show/NCT01968668

Keywords

versioni (1)
  1. 28/11/19 28/11/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

28 novembre 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Diabetic Nephropathies NCT01968668

Inglese

Eligibility Diabetic Nephropathies NCT01968668

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
japanese subjects with type 2 diabetes mellitus and a clinical diagnosis of dn (diabetic nephropathy) treated with at least the minimal recommended dose of an angiotensin converting enzyme inhibitor (acei) and/or angiotensin receptor blocker (arb)
Descrizione

Japanese | Diabetes Mellitus, Non-Insulin-Dependent | Diabetic Nephropathy | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1556094
UMLS CUI [2]
C0011860
UMLS CUI [3]
C0011881
UMLS CUI [4]
C0003015
UMLS CUI [5]
C0521942
subjects with a clinical diagnosis of diabetic nephropathy (dn) based on at least 1 of the following criteria:
Descrizione

Diabetic Nephropathy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011881
persistent very high albuminuria defined as urinary albumin to creatine ratio (uacr) of >/=300 mg/g (>/=34 mg/mmol) in 2 out of 3 first morning void samples and estimated glomerular filtration rate (egfr) >/=30 ml/min/1.73 m2 but <90 ml/min/1.73 m2 chronic kidney disease-epidemiology collaboration (ckd-epi) or
Descrizione

Persistent albuminuria Very high | Urine albumin/creatinine ratio measurement | Estimated Glomerular Filtration Rate | Creatinine-based formula (CKD-EPI)

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C4546070
UMLS CUI [1,2]
C0442804
UMLS CUI [2]
C0455271
UMLS CUI [3]
C3811844
UMLS CUI [4]
C2964649
persistent high albuminuria defined as uacr of >/=30 mg/g but <300 mg/g (>/=3.4 mg/mmol but <34 mg/mmol) in 2 out of 3 first morning void samples and egfr>/=30 ml/min/1.73 m2 but <90 ml/min/1.73 m2 (ckd-epi)
Descrizione

Persistent albuminuria High | Urine albumin/creatinine ratio measurement | Estimated Glomerular Filtration Rate | Creatinine-based formula (CKD-EPI)

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C4546070
UMLS CUI [1,2]
C0205250
UMLS CUI [2]
C0455271
UMLS CUI [3]
C3811844
UMLS CUI [4]
C2964649
serum potassium </=4.8 mmol/l at both the run-in visit and the screening visit
Descrizione

Serum potassium measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0302353
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
non-diabetic renal disease (confirmed by biopsy)
Descrizione

Kidney Disease | Exception Diabetic Nephropathy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0022658
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0011881
known bilateral clinically relevant renal artery stenosis (>75%)
Descrizione

Bilateral renal artery stenosis Percentage

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0856760
UMLS CUI [1,2]
C0439165
glycated hemoglobin(hba1c) >12% at the run-in visit or the screening visit
Descrizione

Hemoglobin A1c measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0474680
uacr >3000 mg/g (339 mg/mmol) in any of the urinary first morning void samples at the run-in visit or screening visit
Descrizione

Urine albumin/creatinine ratio measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0455271
hypertension with mean sitting systolic blood pressure (sbp) >/=180 mmhg or mean sitting diastolic blood pressure (dbp) >/=110 mmhg at the run-in visit or mean sitting sbp >/=160 mmhg or mean sitting dbp >/=100 mmhg at the screening visit
Descrizione

Hypertensive disease | Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319894
UMLS CUI [3,2]
C0444504
subjects with a clinical diagnosis of heart failure with reduced ejection fraction (hfref) and persistent symptoms (new york heart association class ii-iv) at the run-in visit
Descrizione

Heart failure with reduced ejection fraction | Symptoms Persistent | New York Heart Association Classification

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3839346
UMLS CUI [2,1]
C1457887
UMLS CUI [2,2]
C0205322
UMLS CUI [3]
C1275491
concomitant therapy with eplerenone, spironolactone, any renin inhibitor, or potassium-sparing diuretic
Descrizione

eplerenone | Spironolactone | Renin inhibitor | Potassium Sparing Diuretics

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0961485
UMLS CUI [2]
C0037982
UMLS CUI [3]
C1960108
UMLS CUI [4]
C0304490
Ritorna all'inizio della pagina

Similar models

Eligibility Diabetic Nephropathies NCT01968668

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Japanese | Diabetes Mellitus, Non-Insulin-Dependent | Diabetic Nephropathy | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
japanese subjects with type 2 diabetes mellitus and a clinical diagnosis of dn (diabetic nephropathy) treated with at least the minimal recommended dose of an angiotensin converting enzyme inhibitor (acei) and/or angiotensin receptor blocker (arb)
boolean
C1556094 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
C0011881 (UMLS CUI [3])
C0003015 (UMLS CUI [4])
C0521942 (UMLS CUI [5])
Diabetic Nephropathy
Item
subjects with a clinical diagnosis of diabetic nephropathy (dn) based on at least 1 of the following criteria:
boolean
C0011881 (UMLS CUI [1])
Persistent albuminuria Very high | Urine albumin/creatinine ratio measurement | Estimated Glomerular Filtration Rate | Creatinine-based formula (CKD-EPI)
Item
persistent very high albuminuria defined as urinary albumin to creatine ratio (uacr) of >/=300 mg/g (>/=34 mg/mmol) in 2 out of 3 first morning void samples and estimated glomerular filtration rate (egfr) >/=30 ml/min/1.73 m2 but <90 ml/min/1.73 m2 chronic kidney disease-epidemiology collaboration (ckd-epi) or
boolean
C4546070 (UMLS CUI [1,1])
C0442804 (UMLS CUI [1,2])
C0455271 (UMLS CUI [2])
C3811844 (UMLS CUI [3])
C2964649 (UMLS CUI [4])
Persistent albuminuria High | Urine albumin/creatinine ratio measurement | Estimated Glomerular Filtration Rate | Creatinine-based formula (CKD-EPI)
Item
persistent high albuminuria defined as uacr of >/=30 mg/g but <300 mg/g (>/=3.4 mg/mmol but <34 mg/mmol) in 2 out of 3 first morning void samples and egfr>/=30 ml/min/1.73 m2 but <90 ml/min/1.73 m2 (ckd-epi)
boolean
C4546070 (UMLS CUI [1,1])
C0205250 (UMLS CUI [1,2])
C0455271 (UMLS CUI [2])
C3811844 (UMLS CUI [3])
C2964649 (UMLS CUI [4])
Serum potassium measurement
Item
serum potassium </=4.8 mmol/l at both the run-in visit and the screening visit
boolean
C0302353 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Kidney Disease | Exception Diabetic Nephropathy
Item
non-diabetic renal disease (confirmed by biopsy)
boolean
C0022658 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0011881 (UMLS CUI [2,2])
Bilateral renal artery stenosis Percentage
Item
known bilateral clinically relevant renal artery stenosis (>75%)
boolean
C0856760 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
Hemoglobin A1c measurement
Item
glycated hemoglobin(hba1c) >12% at the run-in visit or the screening visit
boolean
C0474680 (UMLS CUI [1])
Urine albumin/creatinine ratio measurement
Item
uacr >3000 mg/g (339 mg/mmol) in any of the urinary first morning void samples at the run-in visit or screening visit
boolean
C0455271 (UMLS CUI [1])
Hypertensive disease | Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean
Item
hypertension with mean sitting systolic blood pressure (sbp) >/=180 mmhg or mean sitting diastolic blood pressure (dbp) >/=110 mmhg at the run-in visit or mean sitting sbp >/=160 mmhg or mean sitting dbp >/=100 mmhg at the screening visit
boolean
C0020538 (UMLS CUI [1])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319894 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Heart failure with reduced ejection fraction | Symptoms Persistent | New York Heart Association Classification
Item
subjects with a clinical diagnosis of heart failure with reduced ejection fraction (hfref) and persistent symptoms (new york heart association class ii-iv) at the run-in visit
boolean
C3839346 (UMLS CUI [1])
C1457887 (UMLS CUI [2,1])
C0205322 (UMLS CUI [2,2])
C1275491 (UMLS CUI [3])
eplerenone | Spironolactone | Renin inhibitor | Potassium Sparing Diuretics
Item
concomitant therapy with eplerenone, spironolactone, any renin inhibitor, or potassium-sparing diuretic
boolean
C0961485 (UMLS CUI [1])
C0037982 (UMLS CUI [2])
C1960108 (UMLS CUI [3])
C0304490 (UMLS CUI [4])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial